Search

everythinglearnresearchcommunity

for

Search:↓

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Erlotinib can cause persistent excessive hair growth.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Recognizing trichofolliculomas is important to avoid unnecessary surgery.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Nilotinib can cause keratosis pilaris, a skin condition.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Tofacitinib is an effective and safe treatment for alopecia areata.

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

Topical folates can penetrate skin and enhance wound healing.

Phaeodactylum tricornutum extract helps hair follicle cells grow by activating the ERK1/2 pathway.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

More research needed to confirm finasteride as standard treatment for FFA.

Fisetin, found in fruits and vegetables, may help treat various health conditions like inflammation, diabetes, heart issues, cancer, and hair loss.

A woman with frontal fibrosing alopecia experienced unusual hair growth after using a specific topical lotion.

Stopping sunscreen use on the forehead led to hair regrowth in a woman with frontal fibrosing alopecia.

QR678 Neo® is a safe and effective treatment for hair loss in men and women.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Congenital triangular alopecia is more common than thought and some treatments can be beneficial for appearance concerns.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Use a combination of oral dutasteride, topical treatments, and hydroxychloroquine to manage frontal fibrosing alopecia.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.